Olivier Outteryck

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies

Andrés Cruz-Herranz, Lisanne J. Balk, Timm Oberwahrenbrock et al. · Neurology · 2016 · 399 citations · Full text

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

Elena H. Martínez‐Lapiscina, Sam Arnow, James A. Wilson et al. · The Lancet Neurology · 2016 · 327 citations

Ocular Disease, Retina, Ophthalmology +6

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

Sven Schippling, LJ Balk, Fiona Costello et al. · Multiple Sclerosis Journal · 2014 · 298 citations

Neuromyelitis optica in France

Nicolas Collongues, Romain Marignier, Hélène Zéphir et al. · Neurology · 2010 · 211 citations